Craig Ballard

444 total citations
18 papers, 338 citations indexed

About

Craig Ballard is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Craig Ballard has authored 18 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 9 papers in Epidemiology and 9 papers in Hepatology. Recurrent topics in Craig Ballard's work include HIV/AIDS drug development and treatment (12 papers), Hepatitis C virus research (9 papers) and HIV/AIDS Research and Interventions (7 papers). Craig Ballard is often cited by papers focused on HIV/AIDS drug development and treatment (12 papers), Hepatitis C virus research (9 papers) and HIV/AIDS Research and Interventions (7 papers). Craig Ballard collaborates with scholars based in United States, Spain and Italy. Craig Ballard's co-authors include William C. Mathews, Edward R. Cachay, Lucas Hill, Francesca J. Torriani, David Wyles, Susanne May, Ronald J. Ellis, Robert K. Heaton, Scott L. Letendre and J. Allen McCutchan and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Anesthesia & Analgesia.

In The Last Decade

Craig Ballard

16 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Craig Ballard United States 10 213 177 153 107 75 18 338
Paola Nasta Italy 12 216 1.0× 167 0.9× 142 0.9× 106 1.0× 97 1.3× 42 404
Girish Prajapati United States 10 249 1.2× 179 1.0× 124 0.8× 95 0.9× 172 2.3× 25 436
Jacob Langness United States 7 305 1.4× 163 0.9× 48 0.3× 127 1.2× 45 0.6× 10 381
Jason T. Hindman United States 8 283 1.3× 72 0.4× 36 0.2× 148 1.4× 107 1.4× 25 314
Julia del Amo Spain 9 232 1.1× 170 1.0× 76 0.5× 69 0.6× 142 1.9× 21 327
Giampaolo Quinzan Italy 9 372 1.7× 91 0.5× 39 0.3× 242 2.3× 124 1.7× 15 433
Rodica Van Solingen‐Ristea United States 11 296 1.4× 119 0.7× 77 0.5× 187 1.7× 38 0.5× 31 375
David E. Koren United States 11 183 0.9× 142 0.8× 37 0.2× 51 0.5× 16 0.2× 20 252
Stanley DeVlaming Canada 7 145 0.7× 328 1.9× 282 1.8× 44 0.4× 19 0.3× 10 385
Jules Mugabo Rwanda 9 246 1.2× 160 0.9× 56 0.4× 119 1.1× 67 0.9× 10 333

Countries citing papers authored by Craig Ballard

Since Specialization
Citations

This map shows the geographic impact of Craig Ballard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig Ballard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig Ballard more than expected).

Fields of papers citing papers by Craig Ballard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig Ballard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig Ballard. The network helps show where Craig Ballard may publish in the future.

Co-authorship network of co-authors of Craig Ballard

This figure shows the co-authorship network connecting the top 25 collaborators of Craig Ballard. A scholar is included among the top collaborators of Craig Ballard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig Ballard. Craig Ballard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ballard, Craig, Jacob Steenblik, Talmage D. Egan, et al.. (2025). Single-Syringe Total Intravenous Anesthesia With Propofol and Remifentanil: A Prospective Cohort Study. Anesthesia & Analgesia. 4 indexed citations
2.
Ballard, Craig, et al.. (2023). Postnatal growth restriction impairs rat lung structure and function. The Anatomical Record. 308(4). 1051–1065.
3.
Ballard, Craig, et al.. (2022). Bilateral Coronal Synostosis and Mega Cisterna Magna: A Case Report. Cureus. 14(6). e25717–e25717. 1 indexed citations
4.
Ballard, Craig, Edward R. Cachay, & Lucas Hill. (2019). The Role of the Clinical Pharmacist in the Management of People Living with HIV in the Modern Antiretroviral Era. PubMed. 21(4). 195–210. 8 indexed citations
5.
Cachay, Edward R., Álvaro Mena, Luís Morano, et al.. (2019). Predictors of Hepatitis C Treatment Failure After Using Direct-Acting Antivirals in People Living With Human Immunodeficiency Virus. Open Forum Infectious Diseases. 6(3). ofz070–ofz070. 23 indexed citations
6.
Cachay, Edward R., Lucas Hill, Francesca J. Torriani, et al.. (2018). Predictors of Missed Hepatitis C Intake Appointments and Failure to Establish Hepatitis C Care Among Patients Living With HIV. Open Forum Infectious Diseases. 5(7). ofy173–ofy173. 21 indexed citations
7.
Cachay, Edward R., et al.. (2017). Validation of a questionnaire to monitor symptoms in HIV-infected patients during hepatitis C treatment. AIDS Research and Therapy. 14(1). 56–56.
8.
Cachay, Edward R., David Wyles, Lucas Hill, et al.. (2015). The Impact of Direct Acting Antivirals in the Cure of HCV in HIV-Infected Patients With Ongoing Barriers to Care. Open Forum Infectious Diseases. 2(suppl_1). 2 indexed citations
9.
Cachay, Edward R., David Wyles, Lucas Hill, et al.. (2015). The Impact of Direct-Acting Antivirals in the Hepatitis C-Sustained Viral Response in Human Immunodeficiency Virus-Infected Patients With Ongoing Barriers to Care. Open Forum Infectious Diseases. 2(4). ofv168–ofv168. 21 indexed citations
10.
Lesko, Catherine R., et al.. (2015). Outcomes of pharmacist-assisted management of antiretroviral therapy in patients with HIV infection: A risk-adjusted analysis. American Journal of Health-System Pharmacy. 72(17). 1463–1470. 17 indexed citations
11.
Cachay, Edward R., Lucas Hill, David Wyles, et al.. (2014). The Hepatitis C Cascade of Care among HIV Infected Patients: A Call to Address Ongoing Barriers to Care. PLoS ONE. 9(7). e102883–e102883. 58 indexed citations
12.
Cachay, Edward R., David Wyles, Francesca J. Torriani, et al.. (2013). High incidence of serious adverse events in HIV-infected patients treated with a telaprevir-based hepatitis C virus treatment regimen. AIDS. 27(18). 2893–2897. 12 indexed citations
13.
Ellis, Ronald J., Scott L. Letendre, Florin Vaida, et al.. (2013). Randomized Trial of Central Nervous System–Targeted Antiretrovirals for HIV-Associated Neurocognitive Disorder. Clinical Infectious Diseases. 58(7). 1015–1022. 92 indexed citations
14.
Cachay, Edward R., Lucas Hill, Craig Ballard, et al.. (2013). Increasing Hepatitis C treatment uptake among HIV-infected patients using an HIV primary care model. AIDS Research and Therapy. 10(1). 9–9. 18 indexed citations
15.
Cachay, Edward R., David Wyles, Miguel Goicoechea, et al.. (2011). Reliability and predictive validity of a hepatitis-related symptom inventory in HIV-infected individuals referred for Hepatitis C treatment. AIDS Research and Therapy. 8(1). 29–29. 4 indexed citations
16.
Mathews, William C., et al.. (2008). Predictive validity of a brief antiretroviral adherence index: Retrospective cohort analysis under conditions of repetitive administration. AIDS Research and Therapy. 5(1). 20–20. 5 indexed citations
17.
Mathews, William C., et al.. (2002). Prevalence, Predictors, and Outcomes of Early Adherence after Starting or Changing Antiretroviral Therapy. AIDS Patient Care and STDs. 16(4). 157–172. 41 indexed citations
18.
Geletko, Sandra M., Craig Ballard, & William C. Mathews. (1995). Health beliefs and discontinuation of zidovudine therapy. American Journal of Health-System Pharmacy. 52(5). 505–507. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paola Nasta Breakdown of academic impact, for papers by Girish Prajapati Breakdown of academic impact, for papers by Jacob Langness Breakdown of academic impact, for papers by Jason T. Hindman Breakdown of academic impact, for papers by Julia del Amo Breakdown of academic impact, for papers by Giampaolo Quinzan Breakdown of academic impact, for papers by Rodica Van Solingen‐Ristea Breakdown of academic impact, for papers by David E. Koren Breakdown of academic impact, for papers by Stanley DeVlaming Breakdown of academic impact, for papers by Jules Mugabo
Rankless by CCL
2026